Global Patterns of QALY and DALY Use in Surgical Cost-Utility Analyses: A Systematic Review

Abstract

BackgroundSurgical interventions are being increasingly recognized as cost-effective global priorities, the utility of which are frequently measured using either quality-adjusted (QALY) or disability-adjusted (DALY) life years. The objectives of this study were to: (1) identify surgical cost-effectiveness studies that utilized a formulation of the QALY or DALY as a summary measure, (2) report on global patterns of QALY and DALY use in surgery and the income characteristics of the countries and/or regions involved, and (3) assess for possible associations between national/regional-income levels and the relative prominence of either measure.Study DesignPRISMA-guided systematic review of surgical cost-effectiveness studies indexed in PubMed or EMBASE prior to December 15, 2014, that used the DALY and/or QALY as a summary measure. National locations were used to classify publications based on the 2014 World Bank income stratification scheme into: low-, lower-middle-, upper-middle-, or high-income countries. Differences in QALY/DALY use were considered by income level as well as for differences in geographic location and year using descriptive statistics (two-sided Chi-squared tests, Fischer’s exact tests in cell counts <5).ResultsA total of 540 publications from 128 countries met inclusion criteria, representing 825 “national studies” (regional publications included data from multiple countries). Data for 69.0% (569/825) were reported using QALYs (2.1% low-, 1.2% lower-middle-, 4.4% upper-middle-, and 92.3% high-income countries), compared to 31.0% (256/825) reported using DALYs (46.9% low-, 31.6% lower-middle-, 16.8% upper-middle-, and 4.7% high-income countries) (p<0.001). Studies from the US and the UK dominated the total number of QALY studies (49.9%) and were themselves almost exclusively QALY-based. DALY use, in contrast, was the most common in Africa and Asia. While prominent published use of QALYs (1990s) in surgical cost-effectiveness studies began approximately 10 years earlier than DALYs (2000s), the use of both measures continues to increase.ConclusionAs global prioritization of surgical interventions gains prominence, it will be important to consider the comparative implications of summary measure use. The results of this study demonstrate significant income- and geographic-based differences in the preferential utilization of the QALY and DALY for surgical cost-effectiveness studies. Such regional variation holds important implications for efforts to interpret and utilize global health policy research. PROSPERO registration number: CRD42015015991

Cost-Effectiveness Analysis of Total Hip Arthroplasty Performed by a Canadian Short-Stay Surgical Team in Ecuador

“…We reported our outcomes in QALYs gained because 15D is validated for that purpose [ 8 ]. In a systematic review of global surgical cost-effectiveness analyses, QALYs were more common, though less so in low- or middle-income countries [ 20 ]. Though these comparator studies reported DALYs, theoretical comparisons between QALYs and DALYs can be made, and occasionally QALYs gained will be close to or equal DALYs averted [ 21 ].…”

Does blindness count? Disability weights for vision loss

“…Over the past two decades, both the disability weight and the DALY have gained credence as important advocacy tools to highlight the burden and impact of disease at a population level. DALYs and quality‐adjusted life years have been used in 825 national studies to demonstrate that surgical interventions are cost‐effective global priorities . Disability weights have been used to estimate the potential global productivity loss associated with uncorrected refractive error, and with uncorrected presbyopia .…”

“…DALYs and quality-adjusted life years have been used in 825 national studies to demonstrate that surgical interventions are costeffective global priorities. 18 Disability weights have been used to estimate the potential global productivity loss associated with uncorrected refractive error, 19 and with uncorrected presbyopia. 20 Multiple organizations advocate 'DALYs averted' as bottom-line performance metrics for guiding strategic and resource prioritization decisions in relation to competing public health interventions.…”

CORR Insights®: What are the Functional Results, Complications, and Outcomes of Using a Custom Unipolar Wrist Hemiarthroplasty for Treatment of Grade III Giant Cell Tumors of the Distal Radius?

“…Finally, thoroughly assessing the ultimate costs to society of these various reconstructive techniques would require assessments (such as qualityand disability-adjusted life years) that would incorporate long-term measures of disease burden normalized to the cost of treating the disease [7]. The road to obtaining meaningful and detailed long-term data on functional outcome, cost, and cost-effectiveness will be difficult, but is the only rational way to advance the surgical treatment of this rare but potentially devastating condition.…”